Genetic Testing for Parkinson's Disease and Movement Disorders in Less Privileged Areas: Barriers and Opportunities

Tan AH 1 , Cornejo-Olivas M 2 , Okubadejo N 3 , Pal PK 4 , Saranza G 5 , Saffie-Awad P 6 Show all authors , Ahmad-Annuar A 7 , Schumacher-Schuh AF 8 , Okeng'o K 9 , Mata IF 10 , Gatto EM 11 , Lim SY 1

Affiliations 

  • 1 Division of Neurology, Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia
  • 2 Neurogenetics Working Group, Universidad Científica del Sur, Lima, Peru
  • 3 Department of Medicine, College of Medicine, University of Lagos, Lagos, Nigeria
  • 4 Department of Neurology, National Institute of Mental Health and Neurosciences (NIMHANS), Bengaluru, India
  • 5 Movement Disorders Service, Section of Neurology, Department of Internal Medicine, Chong Hua Hospital and Vicente Sotto Memorial Medical Center, Cebu, Philippines
  • 6 CETRAM-Centro de Estudios de Transtornos del Movimiento, Clínica Santa María, Santiago, Chile
  • 7 Department of Biomedical Science, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia
  • 8 Departamento de Farmacologia, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil
  • 9 T.M.J. Super Specialized Polyclinic, Dar es Salaam, Tanzania
  • 10 Genomic Medicine Institute, Lerner Research Institute, Genomic Medicine, Cleveland Clinic Foundation, Cleveland, Ohio, USA
  • 11 Department of Neurology, Hospital Sanatorio de la Trinidad Mitre, Instituto de Neurociencias Buenos Aires, School of Medicine, Buenos Aires University, Buenos Aires, Argentina
Mov Disord Clin Pract, 2024 Jan;11(1):14-20.
PMID: 38291851 DOI: 10.1002/mdc3.13903

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

MeSH terms
Similar publications